Morgan Stanley’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.72M | Buy |
|
|||||
|
2025
Q1 | $4.25M | Sell |
|
|||||
|
2024
Q4 | $4.28M | Buy |
|
|||||
|
2024
Q3 | $3.52M | Buy |
|
|||||
|
2024
Q2 | $2.69M | Buy |
|
|||||
|
2024
Q1 | $551K | Sell |
|
|||||
|
2023
Q4 | $1.57M | Buy |
|
|||||
|
2023
Q3 | $449K | Buy |
|
|||||
|
2023
Q2 | $438K | Sell |
|
|||||
|
2023
Q1 | $689K | Sell |
|
|||||
|
2022
Q4 | $2.03M | Sell |
|
|||||
|
2022
Q3 | $3.99M | Sell |
|
|||||
|
2022
Q2 | $5.68M | Buy |
|
|||||
|
2022
Q1 | $8.41M | Buy |
|
|||||
|
2021
Q4 | $2.67M | Sell |
|
|||||
|
2021
Q3 | $3.9M | Sell |
|
|||||
|
2021
Q2 | $8.08M | Sell |
|
|||||
|
2021
Q1 | $10M | Buy |
|
|||||
|
2020
Q4 | $9.73M | Buy |
|
|||||
|
2020
Q3 | $2.78M | Buy |
|
|||||
|
2020
Q2 | $1.35M | Sell |
|
|||||
|
2020
Q1 | $6.12M | Buy |
|
|||||
|
2019
Q4 | $4.59M | Buy |
|
|||||
|
2019
Q3 | $1.26M | Buy |
|
|||||
|
2019
Q2 | $705K | Sell |
|
|||||
|
2019
Q1 | $1.57M | Sell |
|
|||||
|
2018
Q4 | $11.1M | Buy |
|
|||||
|
2018
Q3 | $5.3M | Sell |
|
|||||
|
2018
Q2 | $14.1M | Buy |
|
|||||
|
2018
Q1 | $4.14M | Buy |
|
|||||
|
2017
Q4 | $2.51M | Buy |
|
|||||
|
2017
Q3 | $1.16M | Sell |
|
|||||
|
2017
Q2 | $1.4M | Buy |
|
|||||
|
2017
Q1 | $1.5M | Sell |
|
|||||
|
2016
Q4 | $2.05M | Buy |
|
|||||
|
2016
Q3 | $1.45M | Buy |
|
|||||
|
2016
Q2 | $411K | Buy |
|
|||||
|
2016
Q1 | $175K | Sell |
|
|||||
|
2015
Q4 | $1.39M | Sell |
|
|||||
|
2015
Q3 | $1.92M | Sell |
|
|||||
|
2015
Q2 | $7.13M | Sell |
|
|||||
|
2015
Q1 | $4.2M | Buy |
|
|||||
|
2014
Q4 | $217K | Buy |
|
|||||
|
2014
Q3 | $32K | Sell |
|
|||||
|
2014
Q2 | $84K | Sell |
|
|||||
|
2014
Q1 | $1.62M | Buy |
|